Suppr超能文献

每12小时一次头孢曲松治疗方案对严重细菌感染的疗效。

Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.

作者信息

Maslow M J, Levine J F, Pollock A A, Simberkoff M S, Rahal J J

出版信息

Antimicrob Agents Chemother. 1982 Jul;22(1):103-7. doi: 10.1128/AAC.22.1.103.

Abstract

Eighteen patients with 21 serious infections were treated with ceftriaxone, 1 g intravenously every 12 h, for a mean duration of 8 days. Eighteen gram-negative and two gram-positive organisms were isolated. Sites of infection included blood (three patients), urinary tract (six patients), respiratory tract (seven patients), biliary tract (three patients), ascitic fluid (one patient), and skin (one patient). Serum, bile, and ascitic fluid concentrations of ceftriaxone were in excess of the minimal bactericidal concentration required for the infecting organism in all cases. A bacteriological response was demonstrated in 94% of the infections. A clinical response occurred in four infections from which no pathogens were recovered. In one patient, ceftriaxone failed to eradicate a peritoneal infection due to Bacteroides fragilis. In two patients, superinfection with enterococci developed both during and after therapy. Systemic tolerance to ceftriaxone was excellent.

摘要

18例患有21种严重感染的患者接受了头孢曲松治疗,静脉注射1克,每12小时一次,平均疗程为8天。分离出18株革兰氏阴性菌和2株革兰氏阳性菌。感染部位包括血液(3例患者)、泌尿道(6例患者)、呼吸道(7例患者)、胆道(3例患者)、腹水(1例患者)和皮肤(1例患者)。在所有病例中,头孢曲松的血清、胆汁和腹水浓度均超过感染病原体所需的最低杀菌浓度。94%的感染显示出细菌学反应。在4例未分离出病原体的感染中出现了临床反应。在1例患者中,头孢曲松未能根除脆弱拟杆菌引起的腹膜感染。在2例患者中,治疗期间和治疗后均发生了肠球菌二重感染。头孢曲松的全身耐受性良好。

相似文献

2
Ceftriaxone therapy of serious bacterial infections in adults.头孢曲松治疗成人严重细菌感染
Antimicrob Agents Chemother. 1983 Feb;23(2):261-6. doi: 10.1128/AAC.23.2.261.
3
Efficacy of ceftriaxone in serious bacterial infections.头孢曲松在严重细菌感染中的疗效。
Antimicrob Agents Chemother. 1982 Mar;21(3):402-6. doi: 10.1128/AAC.21.3.402.
5
Ceftriaxone therapy of serious bacterial infections.严重细菌感染的头孢曲松治疗。
J Antimicrob Chemother. 1983 Jul;12(1):65-78. doi: 10.1093/jac/12.1.65.
8
Ceftriaxone (Ro 13-9904) therapy of serious infection.头孢曲松(Ro 13 - 9904)治疗严重感染。
Antimicrob Agents Chemother. 1982 Jul;22(1):36-42. doi: 10.1128/AAC.22.1.36.

引用本文的文献

6
Clinical pharmacokinetics of ceftriaxone.头孢曲松的临床药代动力学。
Clin Pharmacokinet. 1989 Oct;17(4):223-35. doi: 10.2165/00003088-198917040-00002.
7
Pathogenicity of the enterococcus in surgical infections.肠球菌在外科感染中的致病性。
Ann Surg. 1990 Aug;212(2):155-9. doi: 10.1097/00000658-199008000-00007.

本文引用的文献

1
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.广谱头孢菌素Ro 13-9904的药代动力学
Antimicrob Agents Chemother. 1980 Aug;18(2):240-2. doi: 10.1128/AAC.18.2.240.
5
In vitro evaluation of Ro 13-9904.Ro 13-9904的体外评估
Antimicrob Agents Chemother. 1980 Oct;18(4):574-8. doi: 10.1128/AAC.18.4.574.
6
Pharmacokinetics of ceftriaxone in humans.头孢曲松在人体内的药代动力学。
Antimicrob Agents Chemother. 1981 Nov;20(5):634-41. doi: 10.1128/AAC.20.5.634.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验